| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/08/2004 | WO2004028635A1 Ocular gene therapy |
| 04/08/2004 | WO2004028562A2 Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats |
| 04/08/2004 | WO2004028559A1 Anti-angiogenic fragments of pigment epithelium-derived factor (pedf) |
| 04/08/2004 | WO2004028558A1 Preventives/remedies for neurodegenerative disease |
| 04/08/2004 | WO2004028552A1 Method for inducing mammary epithelial cell differentiation |
| 04/08/2004 | WO2004028551A1 Novel agents that modulate eph receptor activity |
| 04/08/2004 | WO2004028479A2 Nouvelles compositions et methodes de traitement du psoriasis |
| 04/08/2004 | WO2004028478A2 Functional mutations in respiratory syncytial virus |
| 04/08/2004 | WO2004028467A2 Diagnosis of bovine viral diarrhea virus |
| 04/08/2004 | WO2004028449A2 Azulene dimer-quenched, near-infrared fluorescent probes |
| 04/08/2004 | WO2004028447A2 Novel compositions and methods for the treatment of psoriasis |
| 04/08/2004 | WO2004028444A2 Parathyroid hormone antagonists and uses thereof |
| 04/08/2004 | WO2004028239A2 Mammal model for autoimmune diseases with dysfunction of socs-1 gene |
| 04/08/2004 | WO2004018499A3 Synthetic heparin-binding growth factor analogs |
| 04/08/2004 | WO2004015096A3 Leech extracts for stents |
| 04/08/2004 | WO2004014952A3 Specific probnp(1-108) antibodies for diagnosing heart failure |
| 04/08/2004 | WO2004013172A3 Fragments of beta-amyloid as targets for vaccination against alzheimer disease |
| 04/08/2004 | WO2004013166A3 S. aureus antigene |
| 04/08/2004 | WO2004009619A3 Protein complexes of the tip60 transcriptional activator protein |
| 04/08/2004 | WO2004009124A3 Ghrelin-carrier conjugates |
| 04/08/2004 | WO2004007702A3 Modulators of chloride intracellular channel 1 protein signaling ____________________________________________________________ |
| 04/08/2004 | WO2004006655A3 Nuclear fertility restorer genes and methods of use in plants |
| 04/08/2004 | WO2004005467A3 Expression of human interferon in transgenic chloroplasts |
| 04/08/2004 | WO2004005339A3 Cationic linear peptides having antibacterial and/or antifungal properties |
| 04/08/2004 | WO2004003152A3 Sos1 inhibitors |
| 04/08/2004 | WO2004003016A3 Marked peptides having affinity for a phospholipid and uses |
| 04/08/2004 | WO2004003015A3 Peptides having affinity for a phospholipid and uses |
| 04/08/2004 | WO2004003006A3 Peptides having antimicrobial properties and compositions containing same in particular for preserving foods |
| 04/08/2004 | WO2004001103A3 Silk biomaterials and methods of use thereof |
| 04/08/2004 | WO2004001004A3 Membrane associated tumor endothelium markers |
| 04/08/2004 | WO2004000884A3 Compositions and methods for apo-b48 and apo-b100 assay |
| 04/08/2004 | WO2004000877A3 Peptides derived from the rabies virus glycoprotein g, ligands of the low-affinity receptor of neurotrophins (p75ntr) and applications thereof |
| 04/08/2004 | WO2004000096A3 Novel bartonella antigen lysate extracts for use in elisa diagnostic |
| 04/08/2004 | WO2003105772A3 Analogs of parathyroid hormone and pth-related protein as bone anabolic agents |
| 04/08/2004 | WO2003104428A3 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/08/2004 | WO2003102207A3 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 04/08/2004 | WO2003102139A3 Erbin as a negative regulator of ras-raf-erk signaling |
| 04/08/2004 | WO2003100015A3 Polypeptide cleavage process |
| 04/08/2004 | WO2003099860A8 Immunogenic composition and peptide sequences for prevention and treatment of an hsv condition |
| 04/08/2004 | WO2003095976A3 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 04/08/2004 | WO2003095482A3 Novel cyclic peptides and use thereof as anti-microbial agents |
| 04/08/2004 | WO2003087372A3 Growth factor derived from hepatome and the use of the same |
| 04/08/2004 | WO2003087144A3 Insecticide proteins from photorabdus luminescens |
| 04/08/2004 | WO2003087122A3 Sequences involved in the phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses, and the use of the same as medicaments |
| 04/08/2004 | WO2003084979A3 Novel peptides and the application thereof in therapy |
| 04/08/2004 | WO2003081246A8 Treatment of congestive heart failure with natriuretic peptide and a diuretic |
| 04/08/2004 | WO2003080795A8 Novel nucleic acids and secreted polypeptides |
| 04/08/2004 | WO2003080646A3 Modified plasminogen activator inhibitor type-1 and methods based thereon |
| 04/08/2004 | WO2003076585A3 Controlled modulation of amino acid side chain length of peptide antigens |
| 04/08/2004 | WO2003076455A3 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
| 04/08/2004 | WO2003075956A3 Use of mixtures of lipopeptides for vaccine production |
| 04/08/2004 | WO2003074653A3 Nucleic acid molecules encoding proteins essential for plant growth and development and uses thereof |
| 04/08/2004 | WO2003068921A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/08/2004 | WO2003066900A3 Eif4e gene mutations and potyvirus resistance |
| 04/08/2004 | WO2003064469A3 Regulation of human hematopoietin receptor-like protein |
| 04/08/2004 | WO2003064468A3 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof |
| 04/08/2004 | WO2003063893A3 Fgfr agonists |
| 04/08/2004 | WO2003059262A3 Method and composition for treating and preventing hiv infection and aids |
| 04/08/2004 | WO2003057900A3 Pseudomonas virulence factors and uses thereof |
| 04/08/2004 | WO2003053158A9 Malleable protein matrix and uses thereof |
| 04/08/2004 | WO2003042249A8 Peptide purification by means of metal ion affinity chromatography |
| 04/08/2004 | WO2003038112B1 A composition and method to alter lean body mass and bone properties in a subject |
| 04/08/2004 | WO2003035683A8 Surfactant protein-d and atherosclerosis |
| 04/08/2004 | WO2003033646A8 Compositions and methods for the modulation of viral maturation |
| 04/08/2004 | WO2003018606A9 Casein derived peptides and uses thereof in therapy |
| 04/08/2004 | WO2003013599A3 Anti-coronavirus vaccine |
| 04/08/2004 | WO2003012102A3 Nucleic acids coding for novel hect domain proteins, their diagnostic and therapeutic uses |
| 04/08/2004 | WO2003007699A3 Transcription factors of cereals |
| 04/08/2004 | WO2002099074A8 Slc7s as modifiers of the p53 pathway and methods of use |
| 04/08/2004 | WO2002090545A3 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide |
| 04/08/2004 | WO2002083169A9 Modified staphylococcal enterotoxins and expression systems therefore |
| 04/08/2004 | WO2002076173A3 Inhibitors of glycosaminoglycans |
| 04/08/2004 | WO2002072792A9 Heterologous fusion protein constructs comprising a leishmania antigen |
| 04/08/2004 | WO2002068601A9 Small peptides capable of modulating the function of cd66 (ceacam) family members |
| 04/08/2004 | WO2002058546A3 Methods for screening for substances which inhibit fp prostanoid receptor |
| 04/08/2004 | WO2002055707A9 Cloning of an inhibitor of antigen-receptor signaling by a retroviral-based functional screen |
| 04/08/2004 | WO2002053712A9 Avian hepatitis e virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis e |
| 04/08/2004 | WO2002045657A3 Ovarian tumor antigen and methods of use therefor |
| 04/08/2004 | WO2001079439A3 A novel polypeptide, a human cannabinoid receptor protein 19 and the polynucleotide encoding the polypeptide |
| 04/08/2004 | US20040068769 Enhancement of freezing tolerance in transgenic plants |
| 04/08/2004 | US20040068768 Comprises meiotic replication protein (MRE11) for use as gene transfer tool in plant transformation; tissue engineering |
| 04/08/2004 | US20040068767 Maize cellulose synthases and uses thereof |
| 04/08/2004 | US20040068764 Method of enhancing virus-resistance in plants and producing virus-immune plants |
| 04/08/2004 | US20040068762 Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements |
| 04/08/2004 | US20040068380 Human gtp-rho binding protein 2 |
| 04/08/2004 | US20040068105 Plant thermogenic genes and proteins |
| 04/08/2004 | US20040068104 Comprises animal galactose binding proteins for diagnosing cell proliferative disorders |
| 04/08/2004 | US20040068099 Comprises interleukin-1 zeta polypeptides (IL-1) for diagnosis, prevention and treatment of tumors, allergies and infectious diseases |
| 04/08/2004 | US20040068098 Comprises nucleotide sequences coding neurotoxic stress related protein for diagnosis, prevention and treatment of neurodegenerative diseases; antisense and gene therapy |
| 04/08/2004 | US20040068097 Method and materials relating to g protein-coupled receptor-like polypeptides and polynucleotides |
| 04/08/2004 | US20040068096 Human single nucleotide polymorphisms in organic anion transport and multi-drug resistant proteins |
| 04/08/2004 | US20040068095 Comprises polypeptide for diagnosis, prevention and treatment of cell proliferative, inflammatory, nervous system and autoimmune diseases |
| 04/08/2004 | US20040067903 Nucleic acids encoding a novel regulator of g protein signaling, rgs18, and uses thereof |
| 04/08/2004 | US20040067888 Nucleic acid capable of binding to interferons |
| 04/08/2004 | US20040067887 Nucleotide sequences; drug screening; antibody to protein |
| 04/08/2004 | US20040067885 Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer |
| 04/08/2004 | US20040067884 Culture product; purified polypeptides; antiscarring agents; antiinflammatory agents |
| 04/08/2004 | US20040067882 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/08/2004 | US20040067881 Antilipemic agents; anticholesterol agents; antidiabetic agents; hypotensive agents; administering polypeptide |
| 04/08/2004 | US20040067880 Genetic engineered fusion protein |